Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
Open accessPublished version of a preprint
The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Affected women frequently have metabolic disturbances including insulin resistance and dysregulation of glucose homeostasis. PCOS is diagnosed with two different sets of diagnostic criteria, resulting in a phenotypic spectrum of PCOS cases. The genetic similarities between cases diagnosed based on the two criteria have been largely unknown. Previous studies in Chinese and European subjects have identified 16 loci associated with risk of PCOS. We report a fixed-effect, inverse-weighted-variance meta-analysis from 10,074 PCOS cases and 103,164 controls of European ancestry and characterisation of PCOS related traits. We identified 3 novel loci (near PLGRKT, ZBTB16 and MAPRE1), and provide replication of 11 previously reported loci. Only one locus differed significantly in its association by diagnostic criteria; otherwise the genetic architecture was similar between PCOS diagnosed by self-report and PCOS diagnosed by NIH or non-NIH Rotterdam criteria across common variants at 13 loci. Identified variants were associated with hyperandrogenism, gonadotropin regulation and testosterone levels in affected women. Linkage disequilibrium score regression analysis revealed genetic correlations with obesity, fasting insulin, type 2 diabetes, lipid levels and coronary artery disease, indicating shared genetic architecture between metabolic traits and PCOS. Mendelian randomization analyses suggested variants associated with body mass index, fasting insulin, menopause timing, depression and male-pattern balding play a causal role in PCOS. The data thus demonstrate 3 novel loci associated with PCOS and similar genetic architecture for all diagnostic criteria. The data also provide the first genetic evidence for a male phenotype for PCOS and a causal link to depression, a previously hypothesized comorbid disease. Thus, the genetics provide a comprehensive view of PCOS that encompasses multiple diagnostic criteria, gender, reproductive potential and mental health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PCOS is therefore viewed as a polygenic trait that results from an interaction between susceptible genomic variants and the environment.”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The largest GWAS included a meta-analysis of 10,074 PCOS cases and 103,164 controls and identified 19 loci that confer risk for PCOS [29].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The genes associated with these loci involve gonadotrophin action, ovarian steroidogenesis, insulin resistance and type 2 diabetes susceptibility genes.”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Decades of genetic research has therefore characterized PCOS as a polygenic trait that results from interactions between the environment and susceptible genomic traits [27,29,79,88].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A meta-analysis showed that identified loci are linked to genes plausibly associated with the metabolic and reproductive characteristics of PCOS [118].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [118]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Database resources of the National Center for Biotechnology Information: update
Wheeler, D. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,641
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368
A general framework for estimating the relative pathogenicity of human genetic variants
Kircher, M., Witten, D. M., Jain, P., O'Roak, B. J., Cooper, G. M., & Shendure, J. (2014) · Nature Genetics · doi:10.1038/ng.2892 · Cited by 6,183 · cited 1×
“Identified variants were annotated for insight into their biological function using ANNOVAR [50] to assign refGene gene information, SIFT score [51], PolyPhen2 scores [52], CADD scores [53], GERP scores [54] and SiPhy log odds [55].”
MethodLD Score regression distinguishes confounding from polygenicity in genome-wide association studies
Schizophrenia Working Group of the Psychiatric Genomics Consortium, Bulik-Sullivan, B. K., Loh, P.-R., Finucane, H. K., Ripke, S., Yang, J., Patterson, N., Daly, M. J., Price, A. L., & Neale, B. M. (2015) · Nature Genetics · doi:10.1038/ng.3211 · Cited by 5,559
Self-citation
Cited by
Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00078 · Cited by 653
Obesity and polycystic ovary syndrome
Barber, T. M., McCarthy, M. I., Wass, J. A. H., & Franks, S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02587.x · Cited by 631
Self-citationUpdate on PCOS: consequences, challenges, and guiding treatment
Hoeger, K. M., Dokras, A., & Piltonen, T. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa839 · Cited by 610
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“Mendelian randomization has suggested that high BMI 79,82,88–90 , insulin resistance 79 , increased fasting insulin 5 and reduced levels of sex hormone-binding globulin (SHBG) 6,79 may cause PCOS.”
InfluentialSelf-citationObesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
Barber, T. M., Hanson, P., Weickert, M. O., & Franks, S. (2019) · Clinical Medicine Insights: Reproductive Health · doi:10.1177/1179558119874042 · Cited by 411
Self-citationObesity and polycystic ovary syndrome
Barber, T. M., & Franks, S. (2021) · Clinical Endocrinology · doi:10.1111/cen.14421 · Cited by 385
Self-citationAnimal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome
Stener-Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa010 · Cited by 348
Self-citationCurrent Guidelines for Diagnosing PCOS
Christ, J. P., & Cedars, M. I. (2023) · Diagnostics · doi:10.3390/diagnostics13061113 · Cited by 340
Dapas, M., Lin, F. T. J., Nadkarni, G. N., Sisk, R., Legro, R. S., Urbanek, M., Hayes, M. G., & Dunaif, A. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003132 · Cited by 297
“Our approach, therefore, appears to be a more reliable way of identifying subgroups of PCOS cases who have been noted in the literature [91] but have previously been defined using only a single trait like BMI [92–95] or by diagnostic criteria that do not reflect the genetic heterogeneity of the disorder [22].”
BackgroundResultInfluentialSelf-citationDeconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Self-citationResistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
Ding, H., Zhang, J., Zhang, F., Zhang, S., Chen, X., Liang, W., & Xie, Q. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.741764 · Cited by 228
“Pancreatic -cell dysfunction is another risk associated with PCOS and type 2 diabetes (49).”
BackgroundPolycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke
Zhu, T., Cui, J., & Goodarzi, M. O. (2021) · Diabetes · doi:10.2337/db20-0800 · Cited by 226
Self-citationEpigenetic inheritance of polycystic ovary syndrome — challenges and opportunities for treatment
Stener-Victorin, E., & Deng, Q. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00517-x · Cited by 212
Self-citationInsulin resistance and PCOS: chicken or egg?
Moghetti, P., & Tosi, F. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01351-0 · Cited by 209
Polycystic ovary syndrome as a metabolic disease
Helvaci, N., & Yildiz, B. O. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 188
“A large-scale meta-analysis of GWAS in women with PCOS of European ancestry suggested a generally similar genetic architecture of PCOS phenotypes defined by different diagnostic criteria 55 .”
InfluentialObesity and risk of female reproductive conditions: A Mendelian randomisation study
Venkatesh, S. S., Ferreira, T., Benonisdottir, S., Rahmioglu, N., Becker, C. M., Granne, I., Zondervan, K. T., Holmes, M. V., Lindgren, C. M., & Wittemans, L. B. L. (2022) · PLOS Medicine · doi:10.1371/journal.pmed.1003679 · Cited by 196
“Genetic instruments for endometriosis (14,926 cases, 189,715 controls) [54], PCOS (10,174 cases, 103,164 controls) [47], and UF (20,406 cases, 223,918 controls) [3] were constructed from index variants identified by the largest European ancestry GWAS for each trait.”
BackgroundMethodSelf-citationPolycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease
Guan, C., Zahid, S., Minhas, A. S., Ouyang, P., Vaught, A., Baker, V. L., & Michos, E. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.009 · Cited by 188
Calcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183
“Moreover, childhood obesity has been correlated with increased PCOS risk as a genetic function [27].”
BackgroundMills, M. C., Tropf, F. C., Brazel, D. M., van Zuydam, N., Vaez, A., eQTLGen Consortium, Agbessi, M., Ahsan, H., Alves, I., Andiappan, A. K., et al. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01135-3 · Cited by 157
“26 Our findings (Supplementary Table 13C) suggest that PCOS leads to later AFB.”
Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
Aversa, A., Vignera, S. L., Rago, R., Gambineri, A., Nappi, R. E., Calogero, A. E., & Ferlin, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00516 · Cited by 184
“Indeed, specific PCOS-susceptibility loci may explain family predisposition and the variable clinical presentation of PCOS, including neuroendocrine, reproductive, and metabolic abnormalities (70).”
BackgroundRecent advances in the understanding and management of polycystic ovary syndrome
Rocha, A. L., Oliveira, F. R., Azevedo, R. C., Silva, V. A., Peres, T. M., Candido, A. L., Gomes, K. B., & Reis, F. M. (2019) · F1000Research · doi:10.12688/f1000research.15318.1 · Cited by 142
“A recent genome-wide meta-analysis from over 10,000 PCOS cases identified 14 independent loci associated with the risk for PCOS, including three novel loci 10 .”
BackgroundHiam, D., Moreno-Asso, A., Teede, H. J., Laven, J. S. E., Stepto, N. K., Moran, L. J., & Gibson-Helm, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101606 · Cited by 126
“The importance of this has been recently highlighted in a GWAS meta-analysis where it was identified that the SNP rs804279 in the GATA4/NEIL2 gene loci was strongly associated with the NIH diagnostic criteria, which encompasses only hyperandrogenic PCOS phenotypes, compared to the Rotterdam criteria, which also encomp…”
BackgroundResultInfluentialSelf-citationCauses and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization
Zhu, T., & Goodarzi, M. O. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab757 · Cited by 126
Self-citationPolycystic Ovary Syndrome: Pathophysiology and Therapeutic Opportunities
Dong, J., & Rees, D. A. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2023-000548 · Cited by 123
“71 72 These observations indicate a shared ancestry for polycystic ovary syndrome and reinforce the importance of neuroendocrine and metabolic pathways in the pathogenesis of the disease.”
Diagnosis of Polycystic Ovary Syndrome
Chang, S., & Dunaif, A. E. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.002 · Cited by 190
Self-citationWitchel, S. F., Teede, H. J., & Peña, A. S. (2019) · Pediatric Research · doi:10.1038/s41390-019-0615-1 · Cited by 158
Brower, M. A., Hai, Y., Jones, M. R., Guo, X., Chen, Y. D. I., Rotter, J. I., Krauss, R. M., Legro, R. S., Azziz, R., & Goodarzi, M. O. (2019) · Human Reproduction · doi:10.1093/humrep/dey343 · Cited by 115
“Summary results from a recent GWAS meta-analysis for PCOS in Europeans were used as the source of data to construct the instrument variable for PCOS (Day et al., 2018).”
MethodSelf-citationPolycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
parker, J., O'Brien, C., Hawrelak, J., & Gersh, F. (2021) · doi:10.20944/preprints202112.0088.v1 · Cited by 113
Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)
Laven, J. S. E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00023 · Cited by 122
Self-citationPolycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
Parker, J., O’Brien, C., Hawrelak, J., & Gersh, F. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031336 · Cited by 114
“Regardless of the precise timing of the origin of PCOS in humans, the complex metabolic and reproductive gene variants identified in women with PCOS relate to ancient evolutionary-conserved metabolic and reproductive survival pathways (15,29).”
BackgroundYarmolinsky, J. W., Relton, C. L., Lophatananon, A., Muir, K. R., Menon, U., Gentry‐Maharaj, A., Walther, A., Zheng, J., Fasching, P. A., Zheng, W., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002893 · Cited by 114
Genetic effects on the timing of parturition and links to fetal birth weight
Solé-Navais, P., Flatley, C. J., Steinthórsdóttir, V., Vaudel, M., Juodakis, J., Chen, J., Laisk, T., LaBella, A. L., Westergaard, D., Bačelis, J., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01343-9 · Cited by 109
Self-citationMechanisms of intergenerational transmission of polycystic ovary syndrome
Dumesic, D. A., Hoyos, L. R., Chazenbalk, G. D., Naik, R., Padmanabhan, V., & Abbott, D. H. (2020) · Reproduction · doi:10.1530/rep-19-0197 · Cited by 101
Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank
Oliveri, A., Rebernick, R. J., Kuppa, A., Pant, A., Chen, Y., Du, X., Cushing, K. C., Bell, H. N., Raut, C., Prabhu, P., et al. (2024) · Nature Genetics · doi:10.1038/s41588-023-01625-2 · Cited by 110
“34–37,39, respectively, for alanine aminotransferase (ALT), myocardial infarction (MI), SBP, eGFR and PCOS.”
Tyrmi, J. S., Arffman, R. K., Pujol‐Gualdo, N., Kurra, V., Morin-Papunen, L. C., Sliz, E., FinnGen, Piltonen, T., Laisk, T., Kettunen, J., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab250 · Cited by 103
Self-citationDapas, M., Sisk, R., Legro, R. S., Urbanek, M., Dunaif, A., & Hayes, M. G. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02496 · Cited by 92
Self-citationZhang, Y., Ho, K., Keaton, J. M., Hartzel, D. N., Day, F., Justice, A. E., Josyula, N. S., Pendergrass, S. A., Actkins, K., Davis, L. K., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.04.004 · Cited by 91
Self-citationMolecular and genetic insights into human ovarian aging from single-nuclei multi-omics analyses
Jin, C., Wang, X., Yang, J., Kim, S.-S., Hudgins, A. D., Gamliel, A., Pei, M., Contreras, D., Devos, M., Guo, Q., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00762-5 · Cited by 130
Gunning, M. N., Sir Petermann, T., Crisosto, N., van Rijn, B. B., de Wilde, M. A., Christ, J. P., Uiterwaal, C. S. P. M., de Jager, W., Eijkemans, M. J. C., Kunselman, A. R., et al. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmz036 · Cited by 88
“, 2001), suggesting a genetic component (Carey et al., 1993; Urbanek et al., 1999; Day et al., 2018).”
Self-citationImmunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
Kicińska, A. M., Maksym, R., Zabielska-Kaczorowska, M. A., Stachowska, A., & Babińska, A. (2023) · Biomedicines · doi:10.3390/biomedicines11061567 · Cited by 138
Capalbo, A., Poli, M., Riera‐Escamilla, A., Shukla, V., Høffding, M. K., Krausz, C. G., Hoffmann, E. R., & Simón, C. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa044 · Cited by 90
Dobbie, L. J., Pittam, B., Zhao, S. S., Alam, U., Hydes, T., Barber, T. M., & Cuthbertson, D. J. (2023) · Human Reproduction · doi:10.1093/humrep/dead053 · Cited by 95
“PCOS was diagnosed according to NIH, Rotterdam criteria or self-diagnosis (Day et al. , 2018) (Supplementary Figs S1 and S2).”
Phylactou, M., Clarke, S. A., Patel, B., Baggaley, C., Jayasena, C. N., Kelsey, T., Comninos, A. N., Dhillo, W. S., & Abbara, A. (2021) · Clinical Endocrinology · doi:10.1111/cen.14402 · Cited by 93
Liu, D., Gao, X., Pan, X., Zhou, T., Zhu, C., Li, F., Fan, J., Targher, G., & Zhao, J. (2023) · BMC Medicine · doi:10.1186/s12916-023-02775-0 · Cited by 93
Current concepts of polycystic ovary syndrome pathogenesis
Rosenfield, R. L. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000945 · Cited by 77
“GWAS recently showed that half of PCOS families had at least one of 32 rare DENND1A variants r Health, Inc.”
BackgroundInfluentialThe Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits
Lüll, K., Arffman, R. K., Sola‐Leyva, A., Molina, N. M., Aasmets, O., Herzig, K., Plaza‐Díaz, J., Franks, S., Morin-Papunen, L. C., Tapanainen, J. S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa848 · Cited by 95
Self-citationMendelian randomization analyses for PCOS: evidence, opportunities, and challenges
Wang, C., Wu, W., Yang, H., Ye, Z., Zhao, Y., Liu, J., & Mu, L. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.01.005 · Cited by 81
Katsigianni, M., Karageorgiou, V., Lambrinoudaki, I. V., & Siristatidis, C. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0398-0 · Cited by 78
“PCOS [80] and ASD [81] patients, we could identify neither”
BackgroundPractical Approach to Hyperandrogenism in Women
Sharma, A. R., & Welt, C. K. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.008 · Cited by 101
Self-citationMu, L., Ye, Z., Hu, J., Zhang, Y., Chen, K., Sun, H., Li, R., Mao, W., Long, X., Zhang, C., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104492 · Cited by 78
Genetic Variants Associated With Hidradenitis Suppurativa
Sun, Q., Broadaway, K. A., Edmiston, S. N., Fajgenbaum, K., Miller‐Fleming, T. W., Westerkam, L., Melendez-Gonzalez, M. D. M., Bui, H., Blum, F. R., Levitt, B. E., et al. (2023) · JAMA Dermatology · doi:10.1001/jamadermatol.2023.2217 · Cited by 75
Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043140 · Cited by 69
The role of gonadotropin‐releasing hormone neurons in polycystic ovary syndrome
McCartney, C. R., Campbell, R. E., Marshall, J. C., & Moenter, S. M. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13093 · Cited by 94
Mortlock, S., Corona, R. I., Kho, P. F., Pharoah, P., Seo, J.-H., Freedman, M. L., Gayther, S. A., Siedhoff, M. T., Rogers, P. A. W., Leuchter, R., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100542 · Cited by 54
“…with multiple reproductive traits and diseases including PCOS, uterine fibroids, circulating sex hormone levels and menstrual cycle characteristics (Day et al , 2018; Day et al , 2015; Day et al , 2017; Gallagher et al , 2019; Laisk et al , 2018; Mbarek et al , 2016; Ruth et al , 2016; Sapkota et…”
Liu, Q., Zhu, Z., Kraft, P., Deng, Q., Stener-Victorin, E., & Jiang, X. (2022) · BMC Medicine · doi:10.1186/s12916-022-02238-y · Cited by 68
“Despite three MR studies [7, 9, 10] have been conducted to explore the role of adult BMI in PCOS, these studies used a small number of index SNPs (< 100 instruments vs.”
BackgroundResultInfluentialSelf-citationPolycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach
Nautiyal, H., Imam, S. S., Alshehri, S., Ghoneim, M. M., Afzal, M., Alzarea, S. I., Güven, E., Al-Abbasi, F. A., & Kazmi, I. A. (2022) · Biomedicines · doi:10.3390/biomedicines10030540 · Cited by 100
Zhao, Y., Xu, Y., Wang, X., Xu, L., Chen, J., Gao, C., Wu, C., Pan, D., Zhang, Q., Zhou, J., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa125 · Cited by 67
Zhao, R., Jiang, Y., Zhao, S., & Zhao, H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.648701 · Cited by 79
Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome
Joham, A. E., Piltonen, T., Lujan, M. E., Kiconco, S., & Tay, C. T. (2022) · Clinical Endocrinology · doi:10.1111/cen.14757 · Cited by 80
Long‐term health outcomes in young women with polycystic ovary syndrome: A narrative review
Allen, L. A., Shrikrishnapalasuriyar, N., & Rees, D. A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14609 · Cited by 62
“However, the increased risk of symptoms persists even when women with PCOS are matched by BMI with controls.77 The cutaneous manifestations of PCOS (hirsutism, acne and scalp hair loss) are emotionally distressing, while fertility may be another major concern, albeit that depression and anxiety scores remain higher th…”
BackgroundInfluentialPolycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation
Dumesic, D. A., Padmanabhan, V., Chazenbalk, G. D., & Abbott, D. H. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00878-y · Cited by 63
Mathieson, I., Day, F. R., Barban, N., Tropf, F. C., Brazel, D. M., van Heemst, D., Vaez, A., van Zuydam, N. R., Bitarello, B. D., Gardner, E. J., et al. (2023) · Nature Human Behaviour · doi:10.1038/s41562-023-01528-6 · Cited by 72
Self-citationJoo, Y. Y., Actkins, K., Pacheco, J. A., Basile, A. O., Carroll, R., Crosslin, D. R., Day, F., Denny, J. C., Velez Edwards, D. R., Hakonarson, H., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz326 · Cited by 63
Self-citationZhang, X., Liang, B., Zhang, J., Hao, X., Xu, X., Chang, H., Leung, P. C. K., & Tan, J. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111139 · Cited by 67
Heilmann‐Heimbach, S., Hochfeld, L. M., Henne, S. K., & Nöthen, M. M. (2020) · Experimental Dermatology · doi:10.1111/exd.14130 · Cited by 70
The importance of metabolic dysfunction in polycystic ovary syndrome
Visser, J. A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00456-z · Cited by 63
Self-citationComplex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus
Rodgers, R. J., Avery, J. C., Moore, V. M., Davies, M. J., Azziz, R., Stener-Victorin, E., Moran, L. J., Robertson, S. A., Stepto, N. K., Norman, R. J., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0502 · Cited by 60
Self-citationRecent Advances in the Management of Polycystic Ovary Syndrome: A Review Article
Akre, S., Sharma, K., Chakole, S. V., & Wanjari, M. B. (2022) · Cureus · doi:10.7759/cureus.27689 · Cited by 75
“Ovulation inducement is the cornerstone of treatment for infertile PCOS patients who want to become pregnant because 70% of women with PCOS have dysovulation or no ovulation [5].”
BackgroundInfluentialUnderstanding the genetic complexity of puberty timing across the allele frequency spectrum
Kentistou, K. A., Kaisinger, L. R., Stankovic, S., Vaudel, M., de Oliveira, E. M., Messina, A., Walters, R. G., Liu, X., Busch, A. S., Helgason, H., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01798-4 · Cited by 85
Self-citationThe polycystic ovary syndrome and gynecological cancer risk
Męczekalski, B., Pérez‐Roncero, G. R., López-Baena, M. T., Chedraui, P. A., & Pérez-López, F. R. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1730794 · Cited by 71
“The precise cause of PCOS is unknown, although it has been linked to hyperandrogenism, and genetic and epigenetic factors [8,9].”
BackgroundAlHussain, F., AlRuthia, Y., Al-Mandeel, H., Bellahwal, A., Alharbi, F., Almogbel, Y., Awwad, O., Dala'een, R., & Alharbi, F. A. (2020) · Patient Preference and Adherence · doi:10.2147/ppa.s244273 · Cited by 53
The evolutionary biology of endometriosis
Dinsdale, N., Nepomnaschy, P., & Crespi, B. (2021) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoab008 · Cited by 53
Liu, Q., Tang, B., Zhu, Z., Kraft, P. L., Deng, Q., Stener‐Victorin, E., & Jiang, X. (2022) · Diabetologia · doi:10.1007/s00125-022-05746-x · Cited by 63
“Day et al identified a positive type 2 diabetes–PCOS genetic correlation [12] using Diabetologia”
BackgroundMethodResultInfluentialSelf-citationImmune Dysfunction in Polycystic Ovary Syndrome
Banerjee, S., Cooney, L. G., & Stanic, A. K. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2200033 · Cited by 68
“Taken together, inherited and acquired genetic changes as well as environmental exposures appear to link reproductive molecular pathways and immune pathways in the pathogenesis of PCOS.”
BackgroundCriteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review
Peña, A. S., Ethel Codner, D., & Witchel, S. F. (2022) · Diagnostics · doi:10.3390/diagnostics12081931 · Cited by 90
Polycystic ovary syndrome: A metabolic disorder with therapeutic opportunities
Zhang, Y., Chen, Z., & Zhao, H. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.08.002 · Cited by 66
McAllister, J. M., Han, A. X., Modi, B. P., Teves, M. E., Mavodza, G. R., Anderson, Z. L., Shen, T., Christenson, L. K., Archer, K. J., & Strauss, J. F. (2019) · Endocrinology · doi:10.1210/en.2019-00013 · Cited by 56
Chen, H., Zhang, Y., Li, S., Tao, Y., Gao, R., Xu, W., Yang, Y., Cheng, K., Wang, Y., & Qin, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.731569 · Cited by 60
“Genetic association data on PCOS in Europeans were selected from a GWAS meta-analysis of PCOS consisting of 10,074 PCOS cases and 103,164 controls of European ancestry (14).”
MethodPCOS stratification for precision diagnostics and treatment
Joshi, A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1358755 · Cited by 75
“Numerous metabolic features and PCOS are consistently linked to a high degree of shared genetics (Day et al., 2018).”
BackgroundThe Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome
Bourgneuf, C., Bailbé, D., Lamazière, A., Dupont, C., Moldes, M., Farabos, D., Roblot, N., Gauthier, C., d’Argent, E. M., Cohen-Tannoudji, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21308-y · Cited by 56
Why are women with polycystic ovary syndrome obese?
Barber, T. M. (2022) · British Medical Bulletin · doi:10.1093/bmb/ldac007 · Cited by 61
Advances of microfluidic technology in reproductive biology
Nikshad, A., Aghlmandi, A., Safaralizadeh, R., Maleki, L. A., Warkiani, M. E., Khiavi, F. M., & Yousefi, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118767 · Cited by 50
Prevalence and Etiology of Eating Disorders in Polycystic Ovary Syndrome: A Scoping Review
Lalonde-Bester, S., Malik, M., Masoumi, R., Ng, K., Sidhu, S., Ghosh, M., & Vine, D. F. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100193 · Cited by 63
“Most PCOS phenotypes do not show a clear Mendelian pattern of inheritance and the genetic loci linked to PCOS to date account for only 10% of its heritability, which is estimated at 70% [180 – 182].”
BackgroundGenetic Regulation of Physiological Reproductive Lifespan and Female Fertility
McGrath, I. M., Mortlock, S., & Montgomery, G. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052556 · Cited by 45
“84, Figure 2) is associated with increased circulating FSH concentrations [37,44], increased frequency of dizygotic twinning [44], earlier age at menarche and menopause [23,31], shorter menstrual cycles, increased risk of endometriosis [27], and decreased risk of polycystic ovarian syndrome [45].”
BackgroundRisal, S., Li, C., Luo, Q., Fornes, R., Lu, H., Eriksson, G., Manti, M., Ohlsson, C., Lindgren, E., Crisosto, N., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101035 · Cited by 50
Self-citationMartin, S., Tyrrell, J., Thomas, E. L., Bown, M. J., Wood, A. R., Beaumont, R. N., Tsoi, L. C., Stuart, P. E., Elder, J. T., Law, P., et al. (2022) · eLife · doi:10.7554/elife.72452 · Cited by 43
Genetics of Polycystic Ovary Syndrome
Welt, C. K. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.006 · Cited by 43
Self-citationParker, J. (2023) · Life · doi:10.3390/life13041056 · Cited by 47
Harris, H. R., Cushing-Haugen, K. L., Webb, P. M., Nagle, C. M., Jordan, S. J., Australian Ovarian Cancer Study Group, Risch, H. A., Rossing, M. A., Doherty, J. A., Goodman, M. T., et al. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz113 · Cited by 42
Abbott, D. H., Rogers, J., Dumesic, D. A., & Levine, J. E. (2019) · Medical Sciences · doi:10.3390/medsci7120107 · Cited by 47
“Such etiopathogenic mechanism(s) also include the non-hyperandrogenic adult PCOS phenotype (type D), which shares gene variant associations with hyperandrogenic phenotypes [28].”
BackgroundTay, C. T., Teede, H. J., Loxton, D., Kulkarni, J., & Joham, A. E. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104678 · Cited by 41
The Source of Polycystic Ovarian Syndrome
Raperport, C., & Homburg, R. (2019) · Clinical Medicine Insights Reproductive Health · doi:10.1177/1179558119871467 · Cited by 45
Makrinou, E., Drong, A., Christopoulos, G., Lerner, A., Chapa-Chorda, I., Karaderi, T., Lavery, S. A., Hardy, K., Lindgren, C. M., & Franks, S. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110611 · Cited by 49
Self-citationVerdiesen, R. M. G., van der Schouw, Y. T., van Gils, C. H., Verschuren, W. M. M., Broekmans, F. J., Borges, M. C., Soares, A. G., Lawlor, D. A., Eliassen, A. H., Kraft, P. L., et al. (2022) · Human Reproduction · doi:10.1093/humrep/deac028 · Cited by 49
“MR analyses did not support a causal effect of AMH on breast cancer or PCOS, but these finding should be interpreted with caution because we could not robustly explore how valid the instruments were and because of the considerable uncertainty in effect estimates.”
InfluentialSelf-citationWhat causes anovulation in polycystic ovary syndrome?
Franks, S., & Hardy, K. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.03.001 · Cited by 40
Self-citationKho, P. F., Mortlock, S., Amant, F. C., Annibali, D., Ashton, K. A., Attia, J. R., Auer, P. L., Beckmann, M. W., Black, A., Brinton, L. A., et al. (2021) · Human Genetics · doi:10.1007/s00439-021-02312-0 · Cited by 44
Self-citationZhu, J., Pujol‐Gualdo, N., Wittemans, L. B. L., Lindgren, C. M., Laisk, T., Hirschhorn, J. N., & Chan, Y.-M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab838 · Cited by 47
“Because the largest PCOS GWAS meta-analysis was primarily conducted in individuals of European ancestry, and genetic risk scores are less valid with current methodologies when applied to populations with different ancestry due to differences in genetic architecture (3,4), the present analysis was restricted to individ…”
BackgroundSelf-citationHuman DENND1A.V2 Drives Cyp17a1 Expression and Androgen Production in Mouse Ovaries and Adrenals
Teves, M. E., Modi, B. P., Kulkarni, R., Han, A. X., Marks, J. S., Subler, M. A., Windle, J. J., Newall, J. M., McAllister, J. M., & Strauss, J. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072545 · Cited by 38
Epigenetic inheritance of PCOS by developmental programming and germline transmission
Stener‐Victorin, E., & Deng, Q. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.12.002 · Cited by 42
Self-citationTay, C. T., Moran, L. J., Harrison, C. L., Brown, W. J., & Joham, A. E. (2020) · Clinical Endocrinology · doi:10.1111/cen.14205 · Cited by 39
Metadata
- Authors
- Day, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., Magi, R., Saxena, R., Laisk, T., Urbanek, M., Hayes, M. G., Thorleifsson, G., Fernandez-Tajes, J., Mahajan, A., Mullin, B. H., Stuckey, B. G. A., Spector, T. D., Wilson, S. G., Goodarzi, M. O., Davis, L., Obermayer-Pietsch, B., Uitterlinden, A. G., Anttila, V., Neale, B. M., Jarvelin, M.-R., Fauser, B., Kowalska, I., Visser, J. A., Andersen, M., Ong, K., Stener-Victorin, E., Ehrmann, D., Legro, R. S., Salumets, A., McCarthy, M. I., Morin-Papunen, L., Thorsteinsdottir, U., Stefansson, K., the 23andMe Research Team, Styrkarsdottir, U., Perry, J. R. B., Dunaif, A., Laven, J., Franks, S., Lindgren, C. M., & Welt, C. K.
- Affiliations
- University of Cambridge (GB)
- Centre for Human Genetics (GB)
- Cedars-Sinai Medical Center (US)
- Erasmus MC (NL)
- University of Kentucky (US)
- Harvard University (US)
- Broad Institute (US)
- University of Tartu (EE)
- Northwestern University (US)
- The University of Western Australia (AU)
- Vanderbilt University Medical Center (US)
- University of Graz (AT)
- University Medical Center Utrecht (NL)
- Medical University of Białystok (PL)
- University of Southern Denmark (DK)
- University of Chicago (US)
- Pennsylvania State University (US)
- University of Helsinki (FI)
- Oulu University Hospital (FI)
- Imperial College London (GB)
- University of Utah (US)
- Corresponding author
- Lindgren, Cecilia M.
- Welt, Corrine K.
- ORCID
- Day, Felix
- Karaderi, Tugce
- Jones, Michelle R.
- Meun, Cindy
- He, Chunyan
- Drong, Alex
- Kraft, Peter
- Lin, Nan
- Huang, Hongyan
- Broer, Linda
- Saxena, Richa
- Laisk, Triin
- Urbanek, Margrit
- Hayes, M. Geoffrey
- Fernandez-Tajes, Juan
- Mahajan, Anubha
- Mullin, Benjamin H.
- Stuckey, Bronwyn G. A.
- Wilson, Scott G.
- Goodarzi, Mark O.
- Davis, Lea
- Obermayer-Pietsch, Barbara
- Uitterlinden, André G.
- Anttila, Verneri
- Neale, Benjamin M.
- Jarvelin, Marjo-Riitta
- Fauser, Bart
- Kowalska, Irina
- Visser, Jenny A.
- Andersen, Marianne
- Ong, Ken
- Stener-Victorin, Elisabet
- Legro, Richard S.
- Salumets, Andres
- McCarthy, Mark I.
- Morin-Papunen, Laure
- Thorsteinsdottir, Unnur
- Styrkarsdottir, Unnur
- Perry, John R. B.
- Dunaif, Andrea
- Laven, Joop
- Lindgren, Cecilia M.
- Welt, Corrine K.
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-12-19
- Volume
- 14
- Issue
- 12
- Pages
- e1007813
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC6894746
- OpenAlex
- W2795286808
- Semantic Scholar
- 40247e78ab529bf1dee7a3764395adf9e16122b9
- Cited by
- 619
- References
- 138
- Citations by year
- 2026: 59 · 2025: 75 · 2024: 99 · 2023: 149 · 2022: 78 · 2021: 66 · 2020: 54 · 2019: 35 · 2018: 3
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-12-05)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- UWA Profiles and Research Repository (UWA) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DSpace repository (University of Tartu) (submittedVersion, other-oa)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Eastern Mediterranean University Institutional Repository (Eastern Mediterranean University) (submittedVersion, cc-by-nc-nd)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Opin vísindi (Opin vísindi) (submittedVersion, cc-by)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Apollo (cc-by)
- University of Chicago (cc-by)
- Funders
- Medical Research Council (MC_U106179472, MRC G0802782)
- National Cancer Institute (NCI P30CA177558, NCI UM1CA186107)
- European Regional Development Fund (2014-2020.4.01.15-0012)
- European Union Horizon 2020 (692065)
- National Institute of Child Health and Human Development (R01HD065029, R01HD057450, P50HD044405)
- American Diabetes Association (ADA 1-10-CT-57)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK048381)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, genetic architecture, diagnostic criteria, Rotterdam criteria, NIH criteria, hyperandrogenism, insulin resistance, novel genetic loci, ZBTB16, MAPRE1, genetic correlation, obesity, type 2 diabetes, coronary artery disease, serum lipids, fasting insulin, body mass index, menopause timing, depression, gonadotropin regulation, testosterone, Mendelian randomization, linkage disequilibrium score regression
- MeSH terms
- Female, Humans, Phenotype, Polycystic Ovary Syndrome, Cohort Studies, Case-Control Studies, Genetic Predisposition to Disease, White People, Asian People, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.